Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lobbyists Again Coordinate Device Tax Attack

Executive Summary

AdvaMed and MDMA, two rivaling lobby groups, have again come together against a common enemy: the Obamacare medical device excise tax. The groups simultaneously released survey results that argue that permanently repealing the tax would be a boon for their member companies and innovation.

You may also be interested in...



ACA Repeal With Device Tax Demise Due Next Month

The first step to repealing the Affordable Care Act was taken by the Senate early in the morning of Jan. 12 when it passed a budget resolution bill clearing the way for a Republican "repeal-and-replace" package. The bill will include device tax repeal and be brought to incoming President Trump's desk as soon as February, according to congressional leaders.

Industry Backs Price To Head HHS, Believes ACA Repeal Will Result In No Coverage Gaps

Industry representatives – including the head of the Access to Medical Imaging Coalition and a former chief operating officer at Boston Scientific – remain unconcerned about expected major drops in health insurance coverage if a Republican-controlled Congress and HHS secretary appointee Tom Price repeal Obamacare this year, saying that proposed Republican replacement plans will fill the gap. Current HHS Secretary Sylvia Burwell disagrees, and laid out the reasons why in a Jan. 9 speech.

Rep. Paulsen Re-Introduces Bill To Repeal Device Tax

The Minnesota congressman is taking another stab at chopping off the 2.3 medical device excise tax as part of the wider Obamacare repeal actions anticipated for the new Congress.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT104295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel